C&F Financial Corporation (CFFI) Q3 2025 earnings summary

Executive summary

• Net income rose to $7.1 million for Q3 2025 and $20.3 million for the first nine months, up 31.2% and 46.0% year-over-year, driven by higher community and mortgage banking results, partially offset by lower consumer finance income.

• Annualized return on average assets was 1.06% for Q3 2025, up from 0.86% in Q3 2024; annualized return on average equity was 11.60%, up from 9.74%.

• Earnings per share increased to $2.18 for Q3 2025 and $6.22 for the nine months, compared to $1.65 and $4.15 in the prior year.

• Expansion into Southwest Virginia contributed to growth, with a new loan production office in Roanoke opening in July 2025.

Financial highlights

• Net interest income for Q3 2025 was $27.2 million, up from $24.7 million in Q3 2024; net interest margin increased to 4.24% from 4.13%.

• Loans held for investment grew $88.5 million to $1.97 billion; deposits increased $127.2 million to $2.30 billion since December 31, 2024.

• Mortgage banking segment loan originations rose 6.4% year-over-year to $167.0 million in Q3.

• Consumer finance segment loans decreased 1.0% annualized since December 2024 and 2.9% year-over-year.

• Noninterest income for Q3 2025 was $8.8 million, up 1% year-over-year; noninterest expense rose 5.2% to $24.3 million.

Outlook and guidance

• Management expects continued loan growth in community banking, with the consumer finance segment's marine and RV portfolio expected to run off as existing loans are repaid.

• Net interest margin may face short-term pressure from declining market rates, but could benefit from loan repricing and new securities purchases.

• Management remains confident in continued responsible growth, citing strong liquidity, capital position, and asset quality.

• Forward-looking statements highlight expectations for continued loan and deposit growth, stable asset quality, and ongoing strategic expansion.

• The company maintains strong liquidity and capital positions, exceeding all regulatory requirements.